Rare lephants
Screener

Niagen Bioscience, Inc.

NAGE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
10-Q Aug 4, 2026 10-Q
8-K Aug 4, 2026 8-K
SCHEDULE 13G Jul 29, 2026
424B5 Jul 10, 2026 PROSPECTUS SUPPLEMENT
EFFECT Jul 9, 2026
4 Jul 8, 2026 FORM 4
4 Jul 8, 2026 FORM 4
4 Jul 8, 2026 FORM 4
8-K Jun 29, 2026 8-K
S-3 Jun 29, 2026 REGISTRATION STATEMENT
4 Jun 26, 2026 FORM 4
4 Jun 26, 2026 FORM 4
4 Jun 26, 2026 FORM 4
4 Jun 26, 2026 FORM 4
4 Jun 26, 2026 FORM 4
4 Jun 26, 2026 FORM 4
4 Jun 26, 2026 FORM 4
8-K May 6, 2026 8-K
10-Q May 6, 2026 10-Q
ARS Apr 29, 2026 ARS
DEFA14A Apr 29, 2026 DEFA14A
DEF 14A Apr 29, 2026 DEF 14A
4 Apr 27, 2026 FORM 4
8-K Mar 19, 2026 8-K
8-K Mar 4, 2026 8-K
← Newer Page 1 of 40 · 979 filings Older →